A UCSF study gives hope to those suffering from severe cases of bacterial corneal ulcers, which can lead to blindness if left untreated. The use of topical corticosteroids in a randomized controlled trial was found to be neither beneficial nor harmful …
Category: News
Whether We Know It Or Not, We Can "See" Through One Eye At A Time
Although portions of the visible world come in through one eye only, the brain instantaneously takes all that information and creates a coherent image. As far as we know, we “see” with both eyes at once. Now a new study suggests that the brain may know…
Watson, Can You Heal Me Now? Physicians Are Talking
In this discussion, physicians talk about Watson — IBM’s artificial intelligence system that beat Jeopardy! contestants and is now being used at an insurance company to aid in diagnosis. Medscape Family Medicine
IRIDEX introduces optional MicroPulse module
IRIDEX Corporation announced today that it has expanded its product offering by introducing an optional MicroPulse module in the Company’s IQ532 (green) laser system and now provides a complete portfolio of infrared, yellow and green laser systems whic…
Oxford BioMedica Announces US IND Approval For Novel Ocular Product In Usher Syndrome Type 1B
Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), the leading gene-based biopharmaceutical company, announces that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for the Phase …
Topical corticosteroids show promise against bacterial corneal ulcers
A UCSF study gives hope to those suffering from severe cases of bacterial corneal ulcers, which can lead to blindness if left untreated. The use of topical corticosteroids in a randomized controlled trial was found to be neither beneficial nor harmful …
Steroids Help Patients With Worst Corneal Ulcers
Topical corticosteroids can improve visual acuity in patients with severe corneal ulcers, a team of US and Indian researchers has found. Reuters Health Information
FDA approves Oxford BioMedica’s UshStat IND to treat Usher syndrome type 1B
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-bas…
FDA Strengthens Contact Lens Recall
(MedPage Today) — The FDA has raised the recall of CooperVision’s AVAIRA Toric Soft Contact Lenses for Astigmatism to Class I — the agency’s strongest — because silicone residue on the lenses could cause hazy vision, discomfort, or eye injuries.
American Academy of Ophthalmology (AAO) 2011 Annual Meeting
Read clinically focused news coverage of key developments from the meeting. Medscape Ophthalmology
2011 AAO Annual Meeting to Feature New Approach to Learning
This year’s annual meeting of the American Academy of Ophthalmology (AAO) will feature intimate and informal gatherings to provide a less formal venue for learning from the experts. Medscape Medical News
Corneal Tattooing Helps in the Management of Iris Defects
New corneal tattooing techniques may allow surgeons to correct visual disabilities associated with iris defects. Medscape Medical News
Fee for Service: How Long Will It Be Around?
Fee for service is under attack, but its demise won’t be soon and it may never go completely away. Here’s where fee for service stands. Medscape Business of Medicine
Nail Bed Problems Point to Vascular Issues in Glaucoma (CME/CE)
(MedPage Today) — Nail bed vascular abnormalities had a significant association with optic disc hemorrhage and other manifestations of glaucoma, data from a Korean clinical series showed.
Action Medical Research announces grants to investigate conditions affecting babies, children
Action Medical Research – the leading UK-wide medical research charity dedicated to helping babies and children – has today announced grants worth more than £1.3 million for top researchers across the country.
Kids With Blocked Tear Ducts At Higher Risk For "Lazy Eye"
Amblyopia, sometimes referred to as “lazy eye,” is a cause of poor vision in children. It occurs in about 1.6% to 3.6% of the general population. Early treatment is critical, as the first few years are the most important in the development of eyesight….
Stem Cells Harvested From Hair Follicles Used To Reconstruct Damaged Tissue For Patients Who Suffer From LSCD
A young scientist who led research into the use of stem cells from hair follicles to treat the ocular surface disease has been named the winner of the Young Investigator Award by the journal Stem Cells. Dr. Ewa Meyer-Blazejewska will be presented with …
Possible Risks To Retinal Health From Emerging Pharmaceutical Platform
According to new research by University of Kentucky investigators, an emerging pharmaceutical platform used in treating a variety of diseases may produce unintended and undesirable effects on eye function…
GeneDx launches new genetic test to accurately diagnose rare diseases
At the joint conference of the American Society of Human Genetics/International Congress on Human Genetics in Montreal on October 12, GeneDx, one of the foremost genetics laboratories in the world and a subsidiary of Bio-Reference Laboratories, Inc., i…
Children under the age of 3 with NLDO more likely to develop amblyopia
Amblyopia, sometimes referred to as “lazy eye,” is a cause of poor vision in children. It occurs in about 1.6% to 3.6% of the general population. Early treatment is critical, as the first few years are the most important in the development of eyesight….